Nitrogen-containing bisphosphonate induces enhancement of OPG expression and inhibition of RANKL expression via inhibition of farnesyl pyrophosphate synthase to inhibit the osteogenic differentiation and calcification in vascular smooth muscle cells.

MLA

Xu, Wei, et al. “Nitrogen-Containing Bisphosphonate Induces Enhancement of OPG Expression and Inhibition of RANKL Expression via Inhibition of Farnesyl Pyrophosphate Synthase to Inhibit the Osteogenic Differentiation and Calcification in Vascular Smooth Muscle Cells.” BMC Cardiovascular Disorders, vol. 24, no. 1, Sept. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12872-024-04048-x.

APA

Xu, W., Gong, L., Tang, W., & Lu, G. (2024). Nitrogen-containing bisphosphonate induces enhancement of OPG expression and inhibition of RANKL expression via inhibition of farnesyl pyrophosphate synthase to inhibit the osteogenic differentiation and calcification in vascular smooth muscle cells. BMC Cardiovascular Disorders, 24(1), 1–11. https://doi.org/10.1186/s12872-024-04048-x

Chicago

Xu, Wei, Lifeng Gong, Weigang Tang, and Guoyuan Lu. 2024. “Nitrogen-Containing Bisphosphonate Induces Enhancement of OPG Expression and Inhibition of RANKL Expression via Inhibition of Farnesyl Pyrophosphate Synthase to Inhibit the Osteogenic Differentiation and Calcification in Vascular Smooth Muscle Cells.” BMC Cardiovascular Disorders 24 (1): 1–11. doi:10.1186/s12872-024-04048-x.